[THE EFFECT OF OF POLY(ADP-RIBOSE) POLYMERASE INHIBITOR 4-HYDROXY-QUINAZOLINE ON DEATH OF IMMUNE CELLS UNDER IMMUNE

Fiziolohichnyi Zhurnal (Kiev, Ukraine : 1994)
|July 6, 2018
PubMed

Insights

Poly(ADP-ribose) polymerase (PARP) inhibitor 4-hydroxyquinazoline (4-HQ) reduced DNA damage and cell death in mice with immune complex injury. PARP inhibition shows potential for preventing and treating immune complex diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Immune complex-mediated pathology can lead to significant DNA damage and cell death in immune cells.
  • Poly(ADP-ribose) polymerase (PARP) is implicated in cellular responses to DNA damage.

Purpose of the Study:

  • To investigate the cytoprotective effect of the PARP inhibitor 4-hydroxyquinazoline (4-HQ) in a mouse model of immune complex injury.
  • To assess the impact of 4-HQ on DNA damage and cell viability in thymic and lymph node cells.

Main Methods:

  • Induction of immune complex pathology in CBA mice via long-term immunization with bovine serum albumin (BSA).
  • Comet assay to quantify DNA damage index in immune cells.
  • Assessment of thymic and lymph node cell viability and necrosis.
  • Treatment of immunized mice with the PARP inhibitor 4-HQ.

Main Results:

  • Immune complex pathology significantly increased DNA damage in immune cells (4.0-fold increase).
  • The percentage of thymic and lymph node cells with strong DNA damage increased to 77% and 80%, respectively.
  • 4-HQ treatment reduced genotoxic stress, decreasing DNA-damaged lymphocytes and increasing cells with intact DNA.
  • PARP inhibition demonstrated a strong cytoprotective effect, increasing cell viability primarily by reducing necrosis.

Conclusions:

  • PARP plays a role in thymic and lymph node cell damage during immune complex-mediated pathology.
  • Inhibition of PARP by 4-HQ offers a potential therapeutic strategy for preventing and treating immune complex diseases.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.2K
What is the Immune System?01:38

What is the Immune System?

Overview
130.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.5K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
84.0K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
686
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.9K